Join the “New Developments in PCNSL Treatment” webinar to learn about new research, clinical trials, specialists, ...

March 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it approved Bristol Myers Squibb's combination ...

Subscribe to our newsletter for the latest sci-tech news updates. The study, published in Nature Genetics, was co-led by Michael Green, Ph.D., professor of Lymphoma/Myeloma, and Linghua Wang, MD, Ph.D ...

Clinical trials provide patients with relapsed or treatment-resistant lymphoma access to emerging therapies, making conversations with providers essential, according to Dr. Jennif ...

In a study published today in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of ...

This may make you think before you ink. A study of people in Sweden found that those who had gotten tattoos were 21% more likely to have subsequently been diagnosed with malignant lymphoma. And the ...

VCU Massey is the first U.S. site in a global phase 2a trial for PTX-100, targeting cutaneous T-cell lymphoma. The BIPAVE-001 trial is evaluating AI-081, a PD-1 and VEGF bispecific antibody, for ...

Traits of noncancerous cells in diffuse large B-cell lymphoma (DLBCL) tumors appear to offer insight into which patients will benefit the most from chimeric antigen receptor (CAR) T-cell therapy, ...

High glyphosate use is linked to elevated rates of non-Hodgkin lymphoma cancer, particularly in Iowa and the Upper Midwest, ...

In Iowa, the Food & Water Watch report concludes that 82% of high-spray counties have elevated rates of non-Hodgkin lymphoma.

Readers will learn how veterinary oncologists stage and treat canine lymphoma using modern multi-agent chemotherapy and ...